Article ; Online: Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments.
Critical reviews in oncology/hematology
2020 Volume 151, Page(s) 102982
Abstract: SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment ... ...
Abstract | SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents. |
---|---|
MeSH term(s) | Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/drug therapy ; Drug Interactions ; Humans ; Pandemics ; Pneumonia, Viral/drug therapy ; SARS-CoV-2 |
Chemical Substances | Antineoplastic Agents |
Keywords | covid19 |
Language | English |
Publishing date | 2020-05-12 |
Publishing country | Netherlands |
Document type | Journal Article ; Review |
ZDB-ID | 605680-5 |
ISSN | 1879-0461 ; 0737-9587 ; 1040-8428 |
ISSN (online) | 1879-0461 |
ISSN | 0737-9587 ; 1040-8428 |
DOI | 10.1016/j.critrevonc.2020.102982 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1931: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.